Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 13–24 of 76 articles · Understand the science
- Understand the science
How the 2026 compounding policy treats single ingredients
BPC-157 is a synthetic 15-amino-acid peptide, and TB-500 is defined in an October 2026 U.S. policy as an acetylated seven-amino-acid fragment related to thymosin beta-4. The policy gives each substance its own identity and addresses a specific question about compounding under federal law.
BPC-157 / TB-5002 sources (2026)
- Understand the science
How REDEFINE 1 researchers studied blood pressure
Cagrilintide is an investigational amylin-based peptide studied alone and as part of CagriSema with semaglutide. An analysis published in December 2025 examined blood pressure readings collected in the REDEFINE 1 weight-management trial.
Cagrilintide3 sources (2023–2026)
- Understand the science
What frozen receptor images show about cagrilintide
Cagrilintide is a long-acting peptide based on amylin, a hormone associated with signals after eating. For the specific question of how the peptide sits in its receptors, the older direct evidence comes from a 2025 study that visualized cagrilintide bound to several versions of the receptor family.
Cagrilintide1 source (2025)
- Understand the science
How a change near one end can affect peptide breakdown
CJC-1295 No DAC generally denotes Mod GRF (1–29), a growth hormone–releasing hormone (GHRH) fragment with four substitutions and no albumin-binding attachment. One of those substitutions helps frame a question about how researchers study peptide stability.
CJC-1295 No DAC2 sources (1989, 2024)
- Understand the science
How a laboratory identified a no-DAC sequence in an unknown sample
CJC-1295 No DAC commonly names Mod GRF (1–29), an engineered version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). How can a laboratory establish that an unknown preparation contains a peptide consistent with that description?
CJC-1295 No DAC2 sources (2010, 2024)
- Understand the science
From a growth hormone signal to an outcome in people
CJC-1295 No DAC generally refers to Mod GRF (1–29), a 29-residue analogue designed around the natural signal for growth hormone release. An important research question is how a hormone measurement could be connected to an outcome that matters to people with growth hormone deficiency.
CJC-1295 No DAC1 source (2024)
- Understand the science
How long did growth hormone and IGF-1 change in early human trials?
CJC-1295 With DAC is an investigational form of a growth hormone–releasing hormone (GHRH) analogue. Its attached drug affinity complex (DAC) allows it to bind to blood proteins. Early studies asked how long the circulating peptide and its effects could be measured in healthy adults.
CJC-1295 With DAC2 sources (2005, 2024)
- Understand the science
What the original albumin-binding experiments established
CJC-1295 With DAC is an engineered form of growth hormone–releasing factor (GRF), also called growth hormone–releasing hormone. Its drug affinity complex (DAC) was designed to react with the blood protein albumin. The original 2005 development study provides older direct evidence for that design.
CJC-1295 With DAC2 sources (2005, 2026)
- Understand the science
Following two signals inside cultured pituitary cells
CJC-1295 (No DAC) / GHRP-2 lists two peptides expected to enter the growth hormone system at different points. The no-DAC label commonly means modified GHRH(1–29). GHRP-2 is a synthetic peptide that stimulates the growth hormone secretagogue pathway.
CJC-1295 (No DAC) / GHRP-22 sources (1998, 2024)
- Understand the science
How structural studies show two different receptor targets
CJC-1295 (No DAC) / GHRP-6 names a modified growth hormone–releasing hormone (GHRH) fragment and a separate synthetic peptide that activates the ghrelin receptor. Structural research helps clarify what it means to give those two signals different receptor targets.
CJC-1295 (No DAC) / GHRP-63 sources (2020–2024)
- Understand the science
What happened when researchers blocked the body's own releasing signal?
CJC-1295 (No DAC) / GHRP-6 names a modified 29-residue analogue of growth hormone–releasing hormone (GHRH) plus a six-residue peptide that stimulates the ghrelin receptor. Does the growth hormone response to GHRP-6 depend on the body's existing GHRH activity?
CJC-1295 (No DAC) / GHRP-62 sources (1998, 2024)
- Understand the science
What a single-compound time course can show about a proposed pairing
CJC-1295 (No DAC) / Ipamorelin names a modified growth hormone–releasing hormone fragment and ipamorelin, a five-residue ghrelin-receptor agonist. Would the timing of ipamorelin's effect by itself predict the timing of the two-peptide response?
CJC-1295 (No DAC) / Ipamorelin2 sources (1999, 2024)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
